Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2000-4-11
pubmed:abstractText
Genetically engineered, neuroattenuated herpes simplex viruses (HSVs) expressing various cytokines can improve survival when used in the treatment of experimental brain tumors. These attenuated viruses have both copies of gamma(1)34.5 deleted. Recently, we demonstrated increased survival of C57BL/6 mice bearing syngeneic GL-261 gliomas when treated with an engineered HSV expressing IL-4, as compared with treatment with the parent construct (gamma(1)34. 5(-)) alone or with a virus expressing IL-10. Herein, we report construction of a conditionally replication-competent mutant expressing both subunits of mIL-12 (M002) and its evaluation in a syngeneic neuroblastoma murine model. IL-12 induces a helper T cell subset type 1 response, which may induce more durable antitumor effects. In vitro studies showed that, when infected with M002, both Vero cells and murine Neuro-2a neuroblastoma cells produced physiologically relevant levels of IL-12 heterodimers, as determined by ELISA. M002 was cytotoxic for Neuro-2a cells and human glioma cell lines U251MG and D54MG. Neurotoxicity studies, as defined by plaque-forming units/LD(50), performed in HSV-1-sensitive A/J strain mice found that M002 was not toxic even at high doses. When evaluated in an intracranial syngeneic neuroblastoma murine model, median survival of M002-treated animals was significantly longer than the median survival of animals treated with R3659, the parent gamma(1)34.5(-) mutant lacking any cytokine gene insert. Immunohistochemical analysis of M002-treated tumors identified a pronounced influx of CD4(+) T cells and macrophages as well as CD8(+) cells when compared with an analysis of R3659-treated tumors. We conclude that M002 produced a survival benefit via oncolytic effects combined with immunologic effects meditated by helper T cells of subset type 1.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/10681459-10077220, http://linkedlifedata.com/resource/pubmed/commentcorrection/10681459-10435106, http://linkedlifedata.com/resource/pubmed/commentcorrection/10681459-1350290, http://linkedlifedata.com/resource/pubmed/commentcorrection/10681459-171586, http://linkedlifedata.com/resource/pubmed/commentcorrection/10681459-1851332, http://linkedlifedata.com/resource/pubmed/commentcorrection/10681459-2066774, http://linkedlifedata.com/resource/pubmed/commentcorrection/10681459-2173860, http://linkedlifedata.com/resource/pubmed/commentcorrection/10681459-3016310, http://linkedlifedata.com/resource/pubmed/commentcorrection/10681459-6268303, http://linkedlifedata.com/resource/pubmed/commentcorrection/10681459-6303940, http://linkedlifedata.com/resource/pubmed/commentcorrection/10681459-7538592, http://linkedlifedata.com/resource/pubmed/commentcorrection/10681459-7585221, http://linkedlifedata.com/resource/pubmed/commentcorrection/10681459-7585498, http://linkedlifedata.com/resource/pubmed/commentcorrection/10681459-7711142, http://linkedlifedata.com/resource/pubmed/commentcorrection/10681459-7719935, http://linkedlifedata.com/resource/pubmed/commentcorrection/10681459-7745709, http://linkedlifedata.com/resource/pubmed/commentcorrection/10681459-7759882, http://linkedlifedata.com/resource/pubmed/commentcorrection/10681459-7877992, http://linkedlifedata.com/resource/pubmed/commentcorrection/10681459-7964989, http://linkedlifedata.com/resource/pubmed/commentcorrection/10681459-8032715, http://linkedlifedata.com/resource/pubmed/commentcorrection/10681459-8386343, http://linkedlifedata.com/resource/pubmed/commentcorrection/10681459-8542424, http://linkedlifedata.com/resource/pubmed/commentcorrection/10681459-8618049, http://linkedlifedata.com/resource/pubmed/commentcorrection/10681459-8664385, http://linkedlifedata.com/resource/pubmed/commentcorrection/10681459-8751593, http://linkedlifedata.com/resource/pubmed/commentcorrection/10681459-8835220, http://linkedlifedata.com/resource/pubmed/commentcorrection/10681459-8876130, http://linkedlifedata.com/resource/pubmed/commentcorrection/10681459-8876132, http://linkedlifedata.com/resource/pubmed/commentcorrection/10681459-8930660, http://linkedlifedata.com/resource/pubmed/commentcorrection/10681459-8958959, http://linkedlifedata.com/resource/pubmed/commentcorrection/10681459-9095405, http://linkedlifedata.com/resource/pubmed/commentcorrection/10681459-9108452, http://linkedlifedata.com/resource/pubmed/commentcorrection/10681459-9295125, http://linkedlifedata.com/resource/pubmed/commentcorrection/10681459-9295129, http://linkedlifedata.com/resource/pubmed/commentcorrection/10681459-9311865, http://linkedlifedata.com/resource/pubmed/commentcorrection/10681459-9336740, http://linkedlifedata.com/resource/pubmed/commentcorrection/10681459-9414254, http://linkedlifedata.com/resource/pubmed/commentcorrection/10681459-9473079, http://linkedlifedata.com/resource/pubmed/commentcorrection/10681459-9536273, http://linkedlifedata.com/resource/pubmed/commentcorrection/10681459-9574551, http://linkedlifedata.com/resource/pubmed/commentcorrection/10681459-9584960, http://linkedlifedata.com/resource/pubmed/commentcorrection/10681459-9716025
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:day
29
pubmed:volume
97
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2208-13
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:10681459-Animals, pubmed-meshheading:10681459-Biological Therapy, pubmed-meshheading:10681459-Brain Neoplasms, pubmed-meshheading:10681459-CD4-Positive T-Lymphocytes, pubmed-meshheading:10681459-CD8-Positive T-Lymphocytes, pubmed-meshheading:10681459-Cercopithecus aethiops, pubmed-meshheading:10681459-Disease Models, Animal, pubmed-meshheading:10681459-Female, pubmed-meshheading:10681459-Gene Expression, pubmed-meshheading:10681459-Genetic Engineering, pubmed-meshheading:10681459-Genetic Vectors, pubmed-meshheading:10681459-Glioma, pubmed-meshheading:10681459-Herpesvirus 1, Human, pubmed-meshheading:10681459-Humans, pubmed-meshheading:10681459-Interleukin-12, pubmed-meshheading:10681459-Mice, pubmed-meshheading:10681459-Mice, Inbred A, pubmed-meshheading:10681459-Neuroblastoma, pubmed-meshheading:10681459-Recombination, Genetic, pubmed-meshheading:10681459-Tumor Cells, Cultured, pubmed-meshheading:10681459-Vero Cells, pubmed-meshheading:10681459-Virulence
pubmed:year
2000
pubmed:articleTitle
Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors.
pubmed:affiliation
Department of Pediatrics, Brain Tumor Research Laboratories, Division of Neurosurgery, Department of Surgery, University of Alabama, Birmingham, AL 35294-3295, USA.
More...